GF
LFCR icon

Genworth Financial’s Lifecore Biomedical LFCR Stock Holding History

Genworth Financial’s Portfolio LFCR Stock Details LFCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$440K Buy
+33,342
New +$461K 0.01% 336

Other funds holding LFCR

GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WC
Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return
KG
Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return
OCG
Opus Capital Group Cincinnati, Ohio $930M AUM 16.14% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

Genworth Financial's LFCR Position: Q2 2013 in Review

Genworth Financial opened a new position in Lifecore Biomedical (LFCR) in Q2 2013: 33,342 shares worth $440K. The stake represents 0.01% of the portfolio and ranks #336 among its holdings.

124 funds tracked by Wall St. Rank hold LFCR as of Q2 2013.

  • Genworth Financial held 33,342 shares of Lifecore Biomedical worth $440K as of Q2 2013.
  • Lifecore Biomedical was a new Genworth Financial position in Q2 2013.
  • Lifecore Biomedical made up 0.01% of Genworth Financial's portfolio in Q2 2013, its #336 holding.
  • 124 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2013.

Based on Genworth Financial's 13F filing for Q2 2013, filed 13 Aug 2013.